"Streptokinase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-.
| Descriptor ID |
D013300
|
| MeSH Number(s) |
D08.811.277.656.300.775 D12.776.124.125.662.537
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptokinase".
Below are MeSH descriptors whose meaning is more specific than "Streptokinase".
This graph shows the total number of publications written about "Streptokinase" by people in this website by year, and whether "Streptokinase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 1 | 2 |
| 1999 | 0 | 2 | 2 |
| 2001 | 1 | 2 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptokinase" by people in Profiles.
-
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models. Med Decis Making. 2017 10; 37(7):790-801.
-
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation. 2007 Dec 04; 116(23):2669-77.
-
The case for thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg. 2005 Sep; 18(3):139-47.
-
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy. Am Heart J. 2004 Nov; 148(5):795-802.
-
Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations. J Bacteriol. 2004 Jan; 186(1):110-21.
-
Successful local fibrinolytic treatment and balloon angioplasty in superior mesenteric arterial embolism: a case report and literature review. Hepatogastroenterology. 2003 May-Jun; 50(51):732-4.
-
In vitro ultrasound augmented clot dissolution--what is the optimal timing of ultrasound application? Cardiovasc Drugs Ther. 2002 Dec; 16(6):521-6.
-
There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study. Thromb Res. 2001 Aug 15; 103(4):337-44.
-
Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries. Echocardiography. 2001 Apr; 18(3):247-57.
-
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies. Circulation. 2001 Feb 20; 103(7):954-60.